quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:27:55·57d
SECFiling
Penumbra Inc. logo

SEC Form 10-K filed by Penumbra Inc.

PEN· Penumbra Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • PEN
    Penumbra Inc.
    Health Care

Recent analyst ratings

  • Dec 18UpdateAnalyst$370.00
  • Dec 11UpdateCitigroup$350.00
  • Nov 18UpdateWells Fargo$15.00
  • Oct 8UpdateNeedham$326.00
  • Sep 2UpdateEvercore ISI$300.00
  • Mar 14UpdateBofA Securities$320.00

Related

  • SEC7h
    SEC Form 425 filed by Penumbra Inc.
  • SEC1d
    SEC Form 425 filed by Penumbra Inc.
  • SEC6d
    SEC Form 425 filed by Penumbra Inc.
  • PR10d
    New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
  • INSIDER17d
    SEC Form 4 filed by Grewal Harpreet
  • SEC22d
    SEC Form DEFM14A filed by Penumbra Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Penumbra Inc.
  • INSIDER37d
    President Narayan Shruthi covered exercise/tax liability with 117 shares, decreasing direct ownership by 0.38% to 30,755 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022